Blast Crisis - 24 Studies Found Completed : Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial : Chronic Myelogenous Leukemia : 2011-06-06 : Drug: nilotinib Other Name: AMN107 Terminated : Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML) : Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic, Accelerated-Phase Drug: Homoharringtonine Completed : STI571 Plus Cytarabine in Treating Patients With Chronic Myelogenous Leukemia : Blastic Phase Chronic Myelogenous Leukemia Chronic Myelogenous : 2001-05-06 : Drug: imatinib mesylate Given Withdrawn : A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia : Chronic Myeloid Leukemia, Blast Crisis Acute Myeloid Leukemia : 2008-01-03 : Drug: Imatinib Mesylate Imatin Completed : 3-AP and Fludarabine in Treating Patients With Myeloproliferative Disorders, Chronic Myelomonocytic Leukemia, or Accelerated Phase or Blastic Phase Chronic Myelogenous Leukemia : Accelerated Phase Chronic Myelogenous Leukemia Atypical Chronic Myeloid Leukemia, BCR-ABL1 N : 2006-09-26 : Drug: fludarabine phosphate Gi Completed : Imatinib Mesylate With Vincristine and Dexamethasone in Acute Lymphoblastic Leukemias With BCR-ABL Positive : Leukemia, Lymphocytic, Acute Philadelphia Chromosome : 2008-07-25 : Drug: Imatinib mesylate imatin Withdrawn : Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia : B-cell Adult Acute Lymphoblastic Leukemia Blastic Phase Chronic Myelog : 2012-08-17 : Drug: nilotinib Given PO Completed : A Phase 1 Study of the HSP90 Inhibitor, STA-9090 in Subjects With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Blast-phase Chronic Myelogenous Leukemia : Acute Myeloid Leukemia Acute Lymphoblastic Leukemia : 2009-08-24 : Drug: STA-9090 (ganetespib) Chemotherapy agent Completed : Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec) : Chronic Myelogenous Leukemia : 2002-07-19 : Drug: decitabine (5-aza-2'deoxycytidine) Terminated : Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED) : Blast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML) : 2009-03-05 : Other: Comparator: Biomarker evaluation Patients on standa <<< Previous | Next >>>
